Please ensure Javascript is enabled for purposes of website accessibility

Why Fastly, Teladoc, and Lemonade Stocks Dipped on Monday

By Daniel Sparks – Aug 16, 2021 at 12:02PM

Key Points

  • Shares of these stocks are down 30% or more this year.
  • Many growth stocks have slid sharply in recent weeks.
  • Investors are skittish on Monday amid news of weaker 10-year Treasury notes and slowing growth in China.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of these three companies have been slammed this year.

What happened

Shares of edge computing specialist Fastly (FSLY -0.47%), telehealth company Teladoc Health (TDOC -3.40%), and insurer Lemonade (LMND 0.15%) all took a hit on Monday. The three stocks declined as much as 6.2%, 4.5%, and 4.1%, respectively. As of 11:05 a.m. EDT, shares of these three companies were down 4.9%, 4.1%, and 1.7%, respectively.

The three companies' shares were likely primarily down because of an overall bearish day in the market. Moreover, growth stocks seem to be getting hit particularly hard on Monday. Fastly, Teladoc, and Lemonade are all growth stocks -- so it makes sense that their shares would fall sharply with many other growth stocks.

A chalkboard sketch of a stock price declining.

Image source: Getty Images.

So what

Capturing the down day for the overall market, the S&P 500 slid about 0.6% as of this writing and the tech-heavy Nasdaq Composite was down 1.2%. But many growth stocks were down several percentage points or more.

Selling pressure on the overall market was likely driven by news of slowing economic growth in China and a dip in the 10-year Treasury note. In addition, news that the Federal Reserve is increasingly considering a plan to begin tapering bond purchases later this year could also be leading to some skittishness in stocks. 

The decline in shares of Fastly, Teladoc, and Lemonade may also represent an extension of generally bearish trends for all three stocks. The companies' shares have slid 54%, 30%, and 41%, respectively this year. All three stocks are down between 7.5% and 15% over the past week.

Now what

Despite downward pressure on these companies' stocks, all three management teams are guiding for meaningful top-line growth this year -- even when excluding benefits from recent acquisitions made by Fastly and Teladoc.

Fastly is guiding for full-year revenue to be between $340 and $350 million, up from $291 million of revenue in 2020. Teladoc expects 2021 revenue to exceed $2 billion, up from about $1.1 billion in 2020. These figures include the benefits of recent acquisitions. Lemonade expects revenue to increase from $94 million in 2020 to between $123 million and $125 million this year. 

Of course, one concern with all three of these companies is that they are not profitable yet. However, this is largely because there are significant growth opportunities for each of these businesses to invest in. Still, investors should look for these companies to increasingly demonstrate there is a clear path to significant profits over the long haul.

Daniel Sparks has no position in any of the stocks mentioned. His clients may own shares of the companies mentioned. The Motley Fool owns shares of and recommends Fastly, Lemonade, Inc., and Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$27.60 (-3.40%) $0.97
Fastly Stock Quote
$8.55 (-0.47%) $0.04
Lemonade, Inc. Stock Quote
Lemonade, Inc.
$19.48 (0.15%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.